Depression Among Heart Attack Survivors Can Be Deadly, Yet Is Often Ignored

Clyde Boyce has been hospitalized 14 times in the past four years.

Boyce, 61, survived two strokes and five operations to unblock arteries around his heart, including three procedures in which doctors propped open his blood vessels with stents. He takes 18 pills a day and gets injections every two weeks with a powerful drug to lower cholesterol.

Yet the disease that came closest to taking Boyce’s life wasn’t a heart condition. It was depression, which led him to attempt suicide twice in the year after his first surgery.

These Preventive Measures Might Help Delay Dementia Or Cognitive Decline

In a landmark report, scientists have endorsed three strategies for preventing dementia and cognitive decline associated with normal aging — being physically active, engaging in cognitive training and controlling high blood pressure.

This is the first time experts convened by the National Academies of Sciences, Engineering and Medicine have deemed scientific evidence strong enough to suggest that preventing dementia and age-related cognitive decline might be possible.

Seven years ago, in a separate report issued by the Agency for Healthcare Research and Quality, scientists said they couldn’t recommend any interventions to forestall or slow cognitive deterioration because state-of-the-art science at that time didn’t offer enough support.

Senate Republicans complain of disarray in healthcare effort

WASHINGTON (Reuters) – U.S. Senate Republicans, scolded by President Donald Trump for failing to overturn Obamacare, tried to salvage their seven-year effort for a new healthcare law on Thursday, but leading senators indicated frustration over shifting goal posts.

Trump on Wednesday told the Senate’s fractured Republican majority to revive a bill to repeal and replace Obamacare that collapsed on Monday after Republicans from both moderate and conservative factions pulled their support.

But after a late-night emergency meeting on how to win over holdouts appeared to yield no progress, senators expressed irritation.

White House developing comprehensive biosecurity strategy: official

ASPEN, Colorado (Reuters) – The Trump administration is developing the first comprehensive strategy to defend the United States against disease pandemics and biological attacks by terrorists, the top White House homeland security official said on Thursday.

“We have not had as a country a comprehensive bio-defense strategy ever,” White House homeland security adviser Thomas Bossert told the annual Aspen Security Forum, in Aspen, Colorado. “It’s high time we had a bio-defense strategy.”

The effort involves retired Admiral Tim Ziemer, who oversaw the Obama administration’s initiative to fight malaria in Africa, and the White House hopes to publish the new strategy “as soon as we can,” said Bossert, who provided no further details.

Stop-Smoking Meds Underused in Post-MI Setting

Action Points

  • Use of prescription smoking cessation medications appeared to be very low among older smokers following a heart attack (myocardial infarction).
  • Note that users of early smoking cessation medications were more frequently younger, female, and white compared with patients who did not use prescription smoking cessation medications early post-MI.

Use of prescription smoking cessation medications appeared to be very low among older smokers following a heart attack, according to an analysis of data from the largest U.S. registry of myocardial infarction patients.

Special Training Plus Medication Might Help People With Advanced Alzheimer’s

News Picture: Special Training Plus Medication Might Help People With Advanced Alzheimer'sBy Amy Norton
HealthDay Reporter

Latest Alzheimers News

TUESDAY, July 18, 2017 (HealthDay News) — People with advanced Alzheimer’s can relearn some basic skills when they receive special training along with medication, a small study suggests.

The research, which included 20 Alzheimer’s patients, tested a program that combines specialized “memory coaching” with other services — including training and support groups for family caregivers.

Researchers found that adding the program to medication — memantine (Namenda) — improved patients’ ability to perform everyday tasks, such as dressing and bathing themselves, over six months.

Dozens of Potential Alzheimer’s Meds in the Pipeline

News Picture: Dozens of Potential Alzheimer's Meds in the Pipeline

Latest Alzheimers News

TUESDAY, July 18, 2017 (HealthDay News) — Nearly three dozen new Alzheimer’s drugs may begin clinical trials in the next five years, researchers say.

That includes 27 drugs in phase 3 clinical trials, which are later in the drug review process. It also includes eight drugs in phase 2 clinical trials, according to an analysis by ResearchersAgainstAlzheimer’s (RA2) investigators, an UsAgainstAlzheimer’s network.

“The Alzheimer’s disease pipeline, marred by decades of failures and underinvestment, is due for big victories,” said George Vradenburg, UsAgainstAlzheimer’s co-founder and chair.

Cinco poderosas razones por las que fracasó el proyecto de salud republicano

Siete años de votos republicanos para “derogar y reemplazar” la Ley de Cuidado de Salud Asequible (ACA) se desmoronaron el martes 18 de junio, cuando quedó claro que el Senado no podría reunir los votos necesarios para ninguna de las tres propuestas separadas que se estaban considerando.

El fracaso, al menos por ahora, rompe una de las promesas clave que los republicanos vienen haciendo a sus votantes desde 2010, cuando ACA se convirtió en ley.

Obamacare Exchanges In Limbo

California’s Obamacare exchange scrubbed its annual rate announcement this week, the latest sign of how the ongoing political drama over the Affordable Care Act is roiling insurance markets nationwide.

The exchange, Covered California, might not wrap up negotiations with insurers and announce 2018 premiums for its 1.4 million customers until mid-August — about a month later than usual. Similar scenarios are playing out across the country as state officials and insurers demand clarity on health care rules and funding, with deadlines fast approaching for the start of open enrollment this fall.

Tobacco industry blocking anti-smoking moves: WHO

GENEVA (Reuters) – The tobacco industry continues to subvert government attempts to prevent tobacco-related deaths, the World Health Organization (WHO) said on Wednesday in a fresh call to counter corporate lobbying and litigation.

Countries with partly state-owned tobacco companies, such as Japan which has a stake in Japan Tobacco Inc, should “firewall” their health policy-setting from their commercial interests, the United Nations agency said.

A Reuters investigation published last week revealed that Philip Morris International Inc is waging a secret campaign to subvert the WHO’s anti-smoking treaty.